HELP
Therapeutics

Revolutionary Innovation

R&D Pipeline

We try to find ways to prolong the healthy lifespans for our mission of Living Better and Longer. We continuously promote the development of allogeneic off-the-shelf cell products focusing on diseases in several fields of the cardiovascular system and others. Meanwhile, we are committed to providing innovative cell therapy products that are safe, effective and affordable for patients.

Therapeutic Area
Name
Proof-of-Concept
Pre-Clinical
IND/Phase I
Phase II
Phase III/NDA
Cardiology
HiCM-188
Advanced Heart Failure(CN)
HiCM-188
Advanced Heart Failure(US)
HiCM-388
Acute Myocardial Infarction(CN)(post-reperfusion)
Orthopedics
HMM-910
Osteoporisis(CN)
Ophthalmology
HiO-630
Dry AMD(CN)

Newsroom